ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

I-Pharm Consulting Group Limited

I-Pharm Consulting Group Limited is an active company incorporated on 29 September 2017 with the registered office located in London, City of London. I-Pharm Consulting Group Limited was registered 7 years ago.
Status
Active
Active since 6 years ago
Company No
10988701
Private limited company
Age
7 years
Incorporated 29 September 2017
Size
Medium
Turnover is under £54M
Under 250 employees
Confirmation
Submitted
Dated 18 February 2025 (6 months ago)
Next confirmation dated 18 February 2026
Due by 4 March 2026 (5 months remaining)
Last change occurred 6 months ago
Accounts
Due Soon
For period 1 Jan ⟶ 31 Dec 2023 (12 months)
Accounts type is Group
Next accounts for period 31 December 2024
Due by 30 September 2025 (22 days remaining)
Learn more about I-Pharm Consulting Group Limited
Contact
Address
Moor Place, 1 Fore Street Avenue
Fore Street Avenue
London
EC2Y 9DT
England
Address changed on 13 Jan 2025 (7 months ago)
Previous address was Level 7 8 Devonshire Square London EC2M 4YJ England
Telephone
020 31892299
Email
Unreported
See All Contacts
People
Officers
6
Shareholders
5
Controllers (PSC)
1
Mr Steven James Lamport-Went
Secretary • Director • British • Lives in UK • Born in Apr 1964
Colin John Lynam
Director • Director • Irish • Lives in Northern Ireland • Born in Dec 1982
Issam Adil Al-Tarafi
Director • British • Lives in UK • Born in May 1975
Stephen Peter McAnaney
Director • British,irish • Lives in England • Born in Jun 1979
Mr Stephen Peter McAnaney
PSC • British • Lives in England • Born in Jun 1979
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
I-Pharm Consulting Limited
Steven James Lamport-Went, , and 2 more are mutual people.
Active
I-Pharm Consulting International Limited
Steven James Lamport-Went, Issam Adil Al-Tarafi, and 2 more are mutual people.
Active
Parallel Consulting Limited
Steven James Lamport-Went and are mutual people.
Active
Apollo Solutions Limited
Steven James Lamport-Went and are mutual people.
Active
White Knight Ventures Limited
Steven James Lamport-Went is a mutual person.
Active
Parallel Group Limited
Steven James Lamport-Went and Issam Adil Al-Tarafi are mutual people.
Active
Apollo Solutions Group Limited
Steven James Lamport-Went and Issam Adil Al-Tarafi are mutual people.
Active
Lex Exec Limited
Colin John Lynam is a mutual person.
Active
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2017–2023)
Period Ended
31 Dec 2023
For period 31 Dec ⟶ 31 Dec 2023
Traded for 12 months
Cash in Bank
£1.11M
Decreased by £1.06M (-49%)
Turnover
£28.31M
Decreased by £13.58M (-32%)
Employees
113
Decreased by 18 (-14%)
Total Assets
£8.82M
Decreased by £3.05M (-26%)
Total Liabilities
-£3.01M
Decreased by £2.35M (-44%)
Net Assets
£5.81M
Decreased by £701K (-11%)
Debt Ratio (%)
34%
Decreased by 11.02% (-24%)
See 10 Year Full Financials
Latest Activity
Own Shares Purchased
6 Months Ago on 3 Mar 2025
Confirmation Submitted
6 Months Ago on 19 Feb 2025
Colin John Lynam Resigned
7 Months Ago on 31 Jan 2025
Shares Cancelled
7 Months Ago on 31 Jan 2025
Registered Address Changed
7 Months Ago on 13 Jan 2025
Own Shares Purchased
9 Months Ago on 9 Dec 2024
Shares Cancelled
9 Months Ago on 6 Dec 2024
Group Accounts Submitted
11 Months Ago on 30 Sep 2024
Confirmation Submitted
11 Months Ago on 17 Sep 2024
Mr Stephen Peter Mcananey (PSC) Details Changed
3 Years Ago on 4 Feb 2022
Get Alerts
Get Credit Report
Discover I-Pharm Consulting Group Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Purchase of own shares.
Submitted on 3 Mar 2025
Confirmation statement made on 18 February 2025 with updates
Submitted on 19 Feb 2025
Termination of appointment of Colin John Lynam as a director on 31 January 2025
Submitted on 11 Feb 2025
Cancellation of shares. Statement of capital on 29 January 2025
Submitted on 31 Jan 2025
Registered office address changed from Level 7 8 Devonshire Square London EC2M 4YJ England to Moor Place, 1 Fore Street Avenue Fore Street Avenue London EC2Y 9DT on 13 January 2025
Submitted on 13 Jan 2025
Purchase of own shares.
Submitted on 9 Dec 2024
Cancellation of shares. Statement of capital on 27 October 2024
Submitted on 6 Dec 2024
Group of companies' accounts made up to 31 December 2023
Submitted on 30 Sep 2024
Confirmation statement made on 4 September 2024 with updates
Submitted on 17 Sep 2024
Director's details changed for Mr Stephen Peter Mcananey on 4 February 2022
Submitted on 4 Sep 2024
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs